Do you routinely perform molecular profiling for potentially actionable targets in patients with advanced pancreatic cancer?   

In your practice, has tumor molecular profiling in pancreatic cancer led to the identification of any actionable targets for which a patient was put on targeted therapy and benefited? 



Answer from: Medical Oncologist at Community Practice